Exploring foci of
2025-02-06
Incident Atrial Fibrillation and Flutter in Patients with Pulmonary Arterial Hypertension: Influence of Right Ventricular Dilatation and Reduced Right Atrial Function
2025-02-06 • Danny Mohama, Pitchaya Worapongsatitaya, Bettia Celestin, Felipe Kazmirczak, Shadi P. Bagherzadeh, Kurt W. Prins, Sasha Z. Prisco, E. K. Weir, Step...
Abstract Background The relationship between right atrial (RA) structural and functional remodeling and risk of atrial fibrillation/flutter (AF/AFL) in pulmonary arterial hypertension (PAH) is understudied. This is important due to the prognostic implications of AF/AFL in PAH. Methods In a multicenter cohort study comprised of 326 PAH patients with no prior history of AF/AFL, we evaluated how RA structure and function, as determined by echocardiography, were associated with AF/AFL. We calculated the incident rate …
Corrupted Blood Incident
The Ox-Bow Incident
Kyūjō Incident
Kerch Strait Incident
1952 Washington, D.C., Ufo Incident
Shinjuku Incident
2016 Donald Trump Las Vegas Rally Incident
Mayerling Incident
Premature Atrial Contraction
Exploring foci of
2023-12-22
Dynamin‐related protein 1 is a critical regulator of mitochondrial calcium homeostasis during myocardial ischemia/reperfusion injury
2023-12-22 • Lin Piao, Yong‐Hu Fang, Michael L. Fisher, Robert B. Hamanaka, Alaa Ousta, Rongxue Wu, Gökhan M. Mutlu, Alfredo J. Garcia, Stephen L. Archer, Willa...
Abstract Dynamin‐related protein 1 (Drp1) is a cytosolic GTPase protein that when activated translocates to the mitochondria, meditating mitochondrial fission and increasing reactive oxygen species (ROS) in cardiomyocytes. Drp1 has shown promise as a therapeutic target for reducing cardiac ischemia/reperfusion (IR) injury; however, the lack of specificity of some small molecule Drp1 inhibitors and the reliance on the use of Drp1 haploinsufficient hearts from older mice have left the role of Drp1 in IR in question.…
Protein Dimer
Protein–Protein Interaction
Ki-67 (Protein)
Sumo Protein
Whey Protein
Globular Protein
Green Fluorescent Protein
G Protein
Proto-Oncogene Tyrosine-Protein Kinase Src
Exploring foci of
2021-06-01
Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop
2021-06-01 • Jane A. Leopold, Steven M. Kawut, Micheala A. Aldred, Stephen L. Archer, Raymond L. Benza, Michael R. Bristow, Evan L. Brittain, Naomi C. Chesler,...
Right ventricular dysfunction is a hallmark of advanced pulmonary vascular, lung parenchymal, and left heart disease, yet the underlying mechanisms that govern (mal)adaptation remain incompletely characterized. Owing to the knowledge gaps in our understanding of the right ventricle (RV) in health and disease, the National Heart, Lung, and Blood Institute commissioned a working group to identify current challenges in the field. These included a need to define and standardize normal RV structure and function in popu…
Heart
Internal Medicine
Medicine
Pulmonary Heart Disease
Disease
Heart Failure
Ventricle (Heart)
Cardiovascular Disease
Lung
Exploring foci of
2016-11-17
Trends and Outcomes of Pulmonary Arterial Hypertension–Related Hospitalizations in the United States
2016-11-17 • Vidhu Anand, Samit S. Roy, Stephen L. Archer, Ε. Kenneth Weir, Sushil Kumar Garg, Sue Duval, Thenappan Thenappan
Analyses of temporal changes in PAH care reveal a significant decrease in PAH-related hospitalizations in the United States, but hospital charges have increased substantially and are increasingly being borne by Medicare. In-hospital mortality remains unchanged, but length of hospitalization has increased. This study should help identify the characteristics of patients with PAH that are associated with increased risk of in-hospital mortality and longer length of hospitalization.
Pulmonary Artery Catheter
Pulmonary Circulation
High-Altitude Pulmonary Edema
Ct Pulmonary Angiogram
Pulmonary Vein
Pulmonary Consolidation
Pulmonary Pleurae
Pulmonary Heart Disease
Pulmonary Fibrosis